Oxford Endovascular Ltd is a medical device company that specializes in the development of innovative solutions to treat brain hemorrhages. The company's flagship product, the Origami device, is designed to prevent brain hemorrhage and is based on technology developed at the University of Oxford's Department of Physics.

Oxford Endovascular is a spin out  from Oxford University developing technology to prevent brain haemorrhage.

OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlow™️  is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan.

Created by world experts in the field, OxiFlow™ has gone through proof of concept pre-clinical studies that will be followed by a 1st in human study en-route to gaining FDA & CE mark.

COM:OXFORDENDOVASCULAR

Oxford Endovascular Ltd

Analysis Not Available